My theory has been that SVFC does not yet have the final go ahead to bring it to market on a commercial scale. The treatments therefore have to be done in a gray area where they keep it off the books, or/and book it with the labs. Once they receive the inevitable approval to gear up (weve been led to believe that SVFC is essentially helping write the rule book for this new tech....and its by far the safest simplest procedure out there, effectively making this the gold standard once the dust settles) theyll start reporting.
Its possible they may be able to report international revenue after they get their patents, but I dont know. Being this early, I chalk any revenue up to research and development. Its when the FDA gives their overall blessing (again, more than a formality but inevitable) and a few intellicell branded centers pop up that the revenue number should start showing up. And holy balls will this thing erupt. Big banks and investors will be throwing their money at this one.